Final Programme - iuphar

FC06 The heart gone wrong; stabilization of cardiac
function
Mon 204 Pharmacokinetic and pharmacodynamic interaction of dronedarone and verapamil in healthy subjects
Christine Gaud, (France), S Doroumian, A Brunet, E Sultan, J Galleyrand
Mon 205 Pharmacokinetics and tolerability of dronedarone in patients with moderate hepatic impairment
Christine Gaud, (France), A Brunet, E Sultan, J Galleyrand, K Lasseter, T Marbury
Mon 206 The oxidative stress predicts a higher coronary risk
Jose Antonio González Correa, (Spain), M Carnero, J Muñoz-Marin, F Reguillo, M Ramajo, J Navarro-
Dorado, S Redondo, JP De la Cruz, T Tejerina
Mon 207 Ambulatory control of arterial pressure in patients with isolated systolic hypertension and associated
ischemic heart disease
Jose Ernesto Groning, (Cuba), R Garcia, D Garcia-Barreto, A Hernandez-Cañero
Mon 208 Potentiation of uterus-relaxing effects of nifedipine with β-adrenergic agonists: Studies on rats and
human myometrium
Judit Hajagos-Tóth, (Hungary), Z Kormányos, G Falkay, R Gáspár
Mon 209 Ginsenoside Rg-1 and salvianolic acid B mediated autophagy and apoptosis in nutrient starvation
cardiac myocytes
Xiao Han, (PR China), J-X Liu, X-Z Li
Mon 210 The role of voltage-dependent anion channel in ischemia/reperfusion injury mediated by chloride
Ming He, (PR China), Z Liao, L Tang, D Yin, F Zou, S Yin
Mon 211 The effects of cannabidiol and the CB1 antagonist AM251 on the depressor responses to ACEA in vivo
Claire Hepburn, (UK), O Keown, S Watt, I Megson, S Leslie, K Kane, C Wainwright
Mon 212 Continuous infusion of a tiny dose of corticosterone improves ageing and hypertension related heart
function impairment and reduces cardiac fibrosis
JJ Rob Hermans, (The Netherlands), M Minnaard-Huiban, IPE Beugels, H van Essen, JJ Debets,
H AJ Struijker-Boudier, JFM Smits
Mon 213 Effects of calcitonin gene-related peptide(CGRP) on the underperfusion with norepinephrine injuries in
diabetic rat hearts
Makie Higuchi, (Japan), T Akamine
Mon 214 Targeting antioxidants to sites of oxidative stress using dual action drugs
Nitya Jani, (Australia), J Ziogas, C Schiesser, C Wright
Mon 215 Fetal de novo cholesterol synthesis is required for neuroectodermal survival and cardiovascular
differentiation in early mouse embryos
Heli Jokela, (Finland), P Rantakari, T Lamminen, L Strauss, R Ola, A-L Mutka, H Gylling, T Miettinen,
P Pakarinen, K Sainio, M Poutanen
Mon 216 Phapmacotherapy of patients with ischemic heart disease and left ventricle dysfunction targeting to
restore inotropic action and bionergetic reserve of myocardium
Ketevan T Kapanadze, (Georgia), GV Sukoyan, MA Rogava
Mon 217 Strategies to induce cardiac electrophysiological properties in C2C12 skeletal myoblasts
X Koenig, E Zebedin-Brandl, M Mille, M Schnuerch, M Koley, MD Mihovilovic, R Cervenka, P Lukacs,
H Todt, Karlheinz Hilber (Austria)
Mon 218 Disrupted ion channel function in dystrophic cardiomyocytes
Xaver Koenig, (Austria), M Mille, S Kimbacher, R Cervenka, P Lukacs, H Todt, RE Bittner, K Hilber
176 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area